For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) – the most common form of non-invasive breast cancer – are at risk of developing more invasive tumors in later years.
April 28, 2010
March 18, 2010
Taking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.
March 17, 2010
Banned chemicals -- present in amounts higher than levels found in recent years in US adults -- are turning up in the blood of young girls being studied in California and Ohio. Robert Hiatt
March 16, 2010
UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.
March 03, 2010
New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.
February 24, 2010
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.
February 03, 2010
UCSF Chancellor Susan Desmond-Hellmann outlines a vision for faster development of better, cheaper drugs to fight cancer.
January 14, 2010
A significant percentage of U.S. women 70 years or older who were severely cognitively impaired received screening mammography that was unlikely to benefit them, according to a study of 2,131 elderly women conducted by researchers from the University of California, San Francisco.
December 29, 2009
A tiny department on the UCSF School of Nursing has yielded big developments, including supplying much of the ammunition informing the most significant public discussions about health and health care over the past half century.
November 18, 2009
The latest recommendations about breast cancer screening are part of a necessary trend toward more personalized, risk-based care, several UCSF experts say.